Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sutent in Metastatic Renal Cell Carcinoma
NCT00254540Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2005
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in renal cell carcinoma (RCC), sponsored by Pfizer. Started Dec 2005; status: completed.
02
Drugs
sunitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00254540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254540.